Entities / Company
Cel-Sci (United States).
company in Vienna, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 11
What's happening
Gone quiet
No new reports in 90+ days-
Partnership negotiations accelerated commercial momentum for head and neck cancer treatment in Saudi Arabia.Some support1 report1 development inside
-
Cel-Sci gained filing designation, attracted Saudi investment funds, and focused on commercialization and procurement in Saudi Arabia.Some support1 report
-
Cel-Sci filed securities with the SEC, with ThinkEquity acting as the sole placement agent.Some support5 reports
No events began in the chosen period. Widen it, or reset.
Around Cel-Sci (United States) this week
News at the entities that move Cel-Sci (United States) most-
FDA StructuralVera Therapeutics and the FDA agreed to shift the assessment of a clinical study.Moves Cel-Sci (United States)
-
ThinkEquity TransactionalAtlasClear Holdings, Inc. presented its plans during a presentation hosted by ThinkEquity.Moves Cel-Sci (United States)
-
Saudi Arabia OperationalThe European Parliament urged the EU to designate the Houthis as terrorists, while Iraq condemned strikes on Saudi Arabia.Moves Cel-Sci (United States)
-
Securities and Exchange Commission StructuralThe Securities and Exchange Commission approved registration statements for Lycia Therapeutics, Inc. on October 1, 2026.Moves Cel-Sci (United States)
Connections
The 5 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Cel-Sci's securities offerings are subject to the regulatory oversight and filing requirements of the Securities and Exchange Commission (Bangladesh).
-
FDA Structural
The FDA regulates Cel-Sci, granting designations and concurring on clinical studies.
-
ThinkEquity Transactional
ThinkEquity served as the sole placement agent and book-running manager for a capital offering involving Cel-Sci.
-
Saudi Arabia Operational
Cel-Sci is actively pursuing market entry, regulatory approval, and partnerships in Saudi Arabia, attracting investment interest.
-
Securities and Exchange Commission Structural
Cel-Sci must file securities with the SEC to comply with regulatory requirements.
History
Events by the month they beganJune 2026
3 events- Partnership negotiations accelerated commercial momentum for head and neck cancer treatment in Saudi Arabia.
- Cel-Sci gained filing designation, attracted Saudi investment funds, and focused on commercialization and procurement in Saudi Arabia.
- Cel-Sci filed securities with the SEC, with ThinkEquity acting as the sole placement agent.